Globus Medical announced a 27% increase in worldwide net sales to $759.9 million for Q1 2026, driven by strong growth in its core spine business and the integration of Nevro. GAAP net income rose 64.7% to $124.3 million, with GAAP diluted EPS up 66.6% to $0.90. The company reaffirmed its 2026 revenue guidance of $3.18-$3.22 billion and raised its non-GAAP EPS forecast to $4.70-$4.80, citing operational efficiencies and expanding market share. This strong start positions Globus Medical for sustained earnings growth and value creation throughout the year.
Zcash (ZEC) is approaching the $600 mark after breaking out of a multi-week consolidation, showing strong bullish momentum. The price has surpassed key moving averages and resistance levels, supported by healthy trading volume and positive technical ...
Ethereum is gaining strength, trading near $1,920 after surpassing its 26-day and 50-day EMAs, signaling renewed buying interest. The next key resistance is the 100-day EMA at around $1,944; a daily close above this could lead Ethereum toward the 200...
Bitcoin (BTC) is showing signs of recovery after a prolonged downtrend, breaking above its 26-day and 50-day exponential moving averages (EMAs) near $63,400 and $64,100 respectively. This technical rebound suggests strengthening short-term momentum a...
ETHSystems, a new Ethereum-focused non-profit backed by Bitmine Immersion Technologies and Ethereum co-founder Joe Lubin, aims to enhance privacy on the Ethereum network for institutional use. This marks the third non-profit stepping in as the Ethere...
Lockheed Martin Ventures, the $1 billion venture capital arm of Lockheed Martin, is expanding into the UK and Europe with a new London office. It plans to invest at least $100 million in defense technology startups to strengthen transatlantic defense...
